Sign in with Google. Opens in new tab
ENTITY
Abbvie Inc

Abbvie Inc (ABBV US)

170
Analysis
Health CareUnited States
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.
more
21 Nov 2022 02:32

Portfolios Built Based on Innovation Score by Datamining Technical Publications

We publish a small cap, midcap and large cap portfolio each comprising of twenty stocks, built entirely based on innovations scores by datamining...

Logo
499 Views
Share
bullishAbbvie Inc
08 Nov 2022 17:46

AbbVie Inc: The DJS Antibodies Acquisition & Other Drivers

AbbVie's results for the past quarter were mixed and the company failed to meet Wall Street expectations with respect to its revenues but managed...

Logo
182 Views
Share
bullishAbbvie Inc
29 Oct 2022 15:20

AbbVie (ABBV US): Q3 Sales Miss as Humira OUS Declines; 2022 Guidance Narrowed; Dividend Raised

AbbVie reported 5% operational revenue growth in Q3, driven by continued strength in non-Humira immunology portfolio. The company has narrowed 2022...

Logo
281 Views
Share
07 Oct 2022 10:30

Myovant Sciences (MYOV US): Rejects Sumitomo’s $2.5B Bid; Remains Open for Better Offer

Myovant has turned down acquisition offer from its largest shareholder, leading to share price volatility. A revised offer or a fresh offer from...

Logo
471 Views
Share
03 Oct 2022 14:07

A Look at How a Portfolio Composed of Our Top Five Innovators in Each Report Would Have Performed

Our datamining reports ranks companies within thematic based on innovation quality. We see strong outperformance in a portfolio built using the top...

Logo
364 Views
Share
x